PAREXEL

Imogene Grimes, Ph.D. has been appointed to vice president of Data Sciences Strategic Services, PAREXEL International Corp. In this role, Dr. Grimes will contribute to the continued expansion of the company’s data science services, including data management, biostatistics, and applications of IT to the clinical development process. Her responsibilities include advising clients on clinical study design, analysis methodology, and related regulatory guidelines. Dr. Grimes provides support for strategic data services, such as preparation of integrated data files suitable for registration packages and preparation of electronic submissions, compliant with regulatory expectations.
   
“The biopharmaceutical industry is undertaking more complex clinical research such as using adaptive designs with the potential to detect safety and efficacy signals earlier. Dr. Grimes will bring experience with advanced statistical methods to PAREXEL, which we believe will be a tremendous asset to our clients in bringing novel treatments to patients sooner,” said Mark A. Goldberg, M.D., president of Clinical Research Services and Perceptive Informatics at PAREXEL International.
   
Prior to joining the company, Dr. Grimes served as vice president, Statistics, Data Management and Informatics at Regeneron Pharmaceuticals, where she provided statistical and data management expertise for all phases of drug development research. Previously, she was vice president Statistics and Data Management at Yamanouchi Pharma America, and held senior management positions at Pfizer and GlaxoSmithKline.